The Women's Health Association (WHA) is a global coalition of researchers, clinicians, and advocates dedicated to advancing rigorous science and ethical design for women worldwide.

Historically, clinical trials and medical research have disproportionately excluded women, leading to a profound "data gap" in our understanding of female physiology, disease presentation, and pharmacological responses.
We are here to change that. By funding female-centric clinical studies and providing diagnostic-grade tools directly to patients and providers, we are building the most comprehensive body of knowledge on reproductive health, hormonal balance, and menopause.
Of healthcare research and innovation is invested in female-specific conditions beyond oncology.
The average delay in diagnosis for women compared to men across over 700 diseases.
Of drugs withdrawn from the market are due to unacceptable side effects specifically in women.
Women are three times more likely to experience adverse drug reactions than men.
Our methodology ensures that every tool, article, and protocol we release meets the highest standards of clinical excellence.
Every tool and protocol is backed by peer-reviewed research and validated by our clinical advisory board.
We build privacy-first platforms that protect sensitive health data with enterprise-grade security.
We champion policy changes and funding initiatives that prioritize women's health outcomes globally.
Our research accounts for diverse populations, ensuring equitable healthcare solutions for all women.
Our clinical advisory board comprises leading voices in obstetrics, gynecology, endocrinology, and reproductive immunology.
Chief Medical Officer
Head of Research
Clinical Director
VP of Patient Advocacy